
|Articles|June 1, 2003
- Pharmaceutical Executive-06-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
over 23 years ago
Picking a Place to Growover 23 years ago
Pfizer Can Mold Its Future by Learning from the Pastover 23 years ago
Reputation: The Inside Storyover 23 years ago
Good Recruitment Practice = Patient Pullover 23 years ago
Networked Pharmaover 23 years ago
On AutopilotAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
3
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
4
Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTech Partnership, RedHill Acquires Commercialization Rights to Rebyota & Clenpiq
5




